Hubert Huckel - Director, Catalyst Pharmaceutical Partners, Inc

As of October 6, 2014


Hubert Huckel Net Worth

  • Net worth is estimated to be at least $8.4M
  • Owns at least 1,304,134 units of Catalyst Pharmaceutical Partners, Inc stock

Hubert Huckel Trading

  • Largest purchase of shares was 125,000 units , worth over $100K on May 29, 2012
  • In total has made about 11 transactions over 6 years
  • Usually trades in February, with the busiest year in 2008
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Hubert Huckel Mailing Address

  • Mailing address is C/o Titan Pharmaceuticals Inc 400 Oyster Point Blvd S San Francisco CA 94080 CA

Catalyst Pharmaceutical Partners, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Patrick J. McEnany 2018 $524,236 $332,063 $ $3,461,504 $3,461,504 $ $3,461,504
Steven R. Miller, COO and CSO 2018 $427,441409,325 $188,600 $ $1,655,195 $1,655,195 $11,000 $1,655,195
Gary Ingenito, CM&RO 2018 $399,373 $194,810 $ $1,666,645 $1,666,645 $26,192 $1,666,645
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm

Catalyst Pharmaceutical Partners, Inc Insider Trading

  • The most recent transaction was 3,612 units sold on December 8, 2021 by Gary Ingenito worth over $25.24K
  • In the last 14 years, insiders at Catalyst Pharmaceutical Partners, Inc sold an estimated value of $5.04M and bought an estimated value of $12.04M
  • The most active traders are Patrick J McEnany, President and CEO,  Charles B. O'Keeffe, Director,  and Philip H Coelho, Director
  • Insider trading is most common in December, with the busiest year in 2021

CATALYST PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1